Editor’s Note: In Monday’s TDN, Bill Finley made reference to Mark Casse’s comments on Clenbuterol in a Mar. 2 Op/Ed in the TDN. Casse sent us this note in response.
Much has changed since my Mar. 2 Op/Ed with regards to Clenbuterol. Canada made big changes to their Clenbuterol policy and, as a result, we have seen almost none of the nonsensical form reversals that had haunted us in the past at Woodbine in 2020. I was elated to see the Clenbuterol changes for 2021 in the Mid-Atlantic region. Also, I commend Louis Cella and Oaklawn for their revised Clenbuterol policies. And just today, I read where The Stronach Group has implemented new Clenbuterol rules for the upcoming Gulfstream Park Championship Meet. Cheers!
My question is, what is taking Kentucky and Louisiana so long to get on board? I am very disappointed that we ran the recent Breeders’ Cup series at Keeneland with the same Clenbuterol rules that have failed us in the past. In life and horse racing, there are not many things I am certain of, but one thing I am positive about is the need for the Horse Integrity and Safety Act to be passed by the Senate. Because only when we have national uniformity of medication rules will inequities of this patchwork quilt that has plagued the sport be solved.
The post Mark Casse On Clenbuterol Changes appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
